معرفی
Anna Gavrilova is a researcher at Rīga Stradiņš University, affiliated with the Department of Pharmaceutical Chemistry under the Faculty of Pharmacy. Her work focuses on medication adherence, direct oral anticoagulant (DOAC) therapies, and health informatics. She contributes to UN Sustainable Development Goal 3 (Good Health and Well-being) through studies on anticoagulant safety, polypharmacy, and electronic prescribing systems.
- Education: Pursuing a PhD in Pharmaceutical Chemistry at Rīga Stradiņš University.
Research Interests: Anna's research spans cardiovascular pharmacology, clinical pharmacy, and health informatics. She investigates DOAC concentration dynamics, cardioversion protocols, and medication error prevention. Her work addresses polypharmacy challenges and leverages technology like electronic prescriptions to enhance patient adherence.
Article Trends: Her publications (2018-2024) emphasize anticoagulant drug monitoring, cardiovascular risk management, and digital health tools. Key subfields include dabigatran stability, rivaroxaban utilization, and amiodarone interactions.
- Scientific Awards: No specific awards are mentioned in the provided text.
Grants and Collaborations: Anna leads a PhD project (2020-2025) on DOAC management and participates in the HBM4LV program. She collaborates with experts across Latvia and Europe on medication safety and environmental health intersections.
